IMDX
Insight Molecular Diagnostics
IMDX
IMDX
58 hedge funds and large institutions have $19.6M invested in Insight Molecular Diagnostics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
58% less capital invested
Capital invested by funds: $47M → $19.6M (-$27.4M)
Holders
58
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$36.2K | |
| 2 | +$21.4K | |
| 3 | +$21.2K | |
| 4 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
+$17.6K |
| 5 |
Renaissance Technologies
New York
|
+$15.5K |
Top Sellers
| 1 | -$489K | |
| 2 | -$271K | |
| 3 | -$196K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$180K |
| 5 |
Goldman Sachs
New York
|
-$176K |